Search Results
EYELEA APPROVED TO TREAT WET AMD IN CANADA
An additional treatment option for people with wet age-related macular degeneration (AMD) will soon be available in Canada. Health Canada has just approved Eyelea, a drug made and marketed by Bayer Inc....
READ MOREVALPROIC ACID: THE PERILS OF USING DRUGS OFF-LABEL
Almost three years ago, scientists at the University of Massachusetts Medical School reported on a preliminary clinical trial of the epilepsy drug, valproic acid, as potential treatment for autosomal dominant retinitis pigmentosa...
READ MORESPOTLIGHT ON SIGHT
READ MOREYOUR DOLLARS AT WORK
READ MORERARE DISEASE DAY: AN UPDATE ON INHERITED RETINAL DISEASE RESEARCH
February 28 is Rare Disease Day. In recognition of the day, Fighting Blindness Canada is raising awareness to drive change for those with rare diseases, including an inherited retinal disease (IRD). New...
READ MOREANNOUNCING THE 2024 CLINICIAN SCIENTIST EMERGING LEADER AWARDS!
We are excited to announce the winners of the 2024 Clinician Scientist Emerging Leader (CSEL) award. These awards give emerging clinician scientists funding to help them further their research projects. Past CSEL...
READ MOREJoin the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.
